We encourage our employees to dream

Then we give them the freedom to reach those dreams

Otsuka

We create innovations for the WORLD

Our Products

Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients’ health and the quality of human life.

PrABILIFY MAINTENA® (aripiprazole)
PrVELTASSA®  (patiromer)

Careers

Start a new Story at Otsuka

Come and work with a team of people who aren’t afraid to challenge convention. This approach can lead to something new, something better.

We aspire to attract best-in-class people and partners. After all, having the right team makes all the difference.

We encourage our employees to dream. Then we give them the freedom to reach for those dreams.

What is your story going to be?

News

August 16, 2022

Otsuka Canada Pharmaceutical Inc. announces Health Canada approval of KORSUVA® (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult hemodialysis patients

MONTREAL, Aug. 16, 2022 /CNW/ – Otsuka Canada Pharmaceutical Inc. (OCPI) today announced that Health Canada has approved KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis.1 KORSUVA is a first-in-class kappa opioid receptor (KOR) agonist that targets the body’s peripheral nervous system. CKD associated pruritus affects an estimated 16,000 Canadians with end-stage renal disease on hemodialysis.2,3

Read the press release

Who We Are
Otsuka Canada Pharmaceutical Inc. (OCPI) is dedicated to improving patients’ health and the quality of human life.
Our Culture
The Otsuka culture and big venture approach is our everyday story and competitive advantage.
Our History
Since 1921 we have nurtured the spirit of curiosity, creativity, and perseverance in our people, to bring healthcare products to patients worldwide.
Community Support
Find out more about how OCPI supports medical education and our involvement in the community.
Location
OCPI has it’s headquarters in Technoparc Montreal, in St-Laurent, Quebec.
Other links

News
About Us

Our products

ABILIFY
ABILIFY MAINTENA
JINARC
KORSUVA
SAMSCA
TAVNEOS
REXULTI
VELPHORO
VELTASSA

Contact us

1 888 997-9017
514 332-3001

email

Medical information and Pharmacovigilance

Location

2250 Alfred-Nobel Boulevard,
St-Laurent, Quebec,
Bureau 301
H4S 2C9

Droits d'auteur Otsuka. Tous droits réservés.
L'information contenue sur ce site s'adresse exclusivement aux Canadiens